Carlton M. Kelly’s research while affiliated with Palo Alto Medical Foundation and other places

What is this page?

This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (2)

Psilocybin and hallucinogenic mushrooms - ERRATUM
  • Article
  • Full-text available

June 2025

·

2 Reads

CNS spectrums

Mathieu Fradet

·

Carlton M Kelly

·

Anna J Donnelly

·

Trisha Suppes
Download
Figure 1. Structure of a typical PT protocol.
Figure 2. Design of the therapy room used for psychedelic studies at the Exploratory Therapeutics Laboratory, Stanford University.
Figure 3. Metabolism of psilocybin and psilocin in humans.
Characteristics of Clinical Studies Evaluating PT for Anxiety and Depressive Symptoms in Cancer Patients
Characteristics of Clinical Studies Evaluating PT for Alcohol Use Disorder
Psilocybin and Hallucinogenic Mushrooms

January 2025

·

163 Reads

·

2 Citations

CNS spectrums

Mathieu Fradet

·

Carlton M. Kelly

·

Anna J. Donnelly

·

Trisha Suppes

Psilocybin therapy has recently emerged as a promising new treatment for depression and other mental health disorders. This chapter summarizes the most recent data on its safety and efficacy. The delivery of psilocybin therapy and its subjective effects are also presented. Furthermore, this chapter outlines our current understanding of psilocybin’s pharmacology and neurobiological effects. Other similar psychedelic substances with encouraging therapeutic potential are briefly presented.

Download